TriangleProton Radiation (NCT02598349)
Proton Radiation trial for Pancreatic Cancer (NCT02598349). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with nonmetastatic pancreatic adenocarcinoma that is unresectable, borderline removable, medically inoperable, or for which surgery is refused. Prior pancreatic resection or abdominal radiation excludes participation.
The idea: combine six weeks of proton radiation with capecitabine tablets taken twice daily only on radiation days. Radiation treats the tumor and selected lymph-node areas; capecitabine interferes with DNA production. Surgery follows eight to sixteen weeks later if scans suggest operability. Researchers assess survival against historical data.
This phase 2 study plans 60 patients. Proton Collaborative Group sponsors three recruiting US sites.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.